(3R,4S,5R,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Term ID

CHEBI:152178

Synonyms

D-galacto-hexopyranosyl-(1->3)-D-galacto-hexopyranosyl-(1->3)-D-galacto-hexopyranosyl-(1->3)-D-galacto-hexopyranosyl-(1->3)-D-galacto-hexopyranosyl-(1->3)-D-galacto-hexopyranosyl-(1->4)-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose
Gal(?1-3)Gal(?1-3)Gal(?1-3)Gal(?1-3)Gal(?1-3)Gal(?1-4)Gal(?1-4)Glc

Definition

References

glygen:G60539QY
glytoucan:G60539QY

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (3R,4S,5R,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype where environments contain (3R,4S,5R,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype modified by environments containing (3R,4S,5R,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype affecting (3R,4S,5R,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Human Disease Model